Glenn Jaffe MD
Cataract Related, Retinal Disease, Uveitis
Professor, Ophthalmology, Duke University School of Medicine
Join to View Full Profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-620-4467
Fax+1 919-681-6474
Dr. Jaffe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1987 - 1989
University of California (San Francisco)Residency, Ophthalmology, 1984 - 1987- University of California (San Francisco)/Mount ZionInternship, Internal Medicine, 1983 - 1984
- University of California San Francisco School of MedicineClass of 1983
Certifications & Licensure
NC State Medical License 1989 - 2025
WI State Medical License 1987 - 1989
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment Start of enrollment: 2004 Mar 01
- Retisert and Cataract Surgery in Patients With Severe Uveitis Start of enrollment: 2006 Sep 01
- Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial Start of enrollment: 2008 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Returning Individual-Level Urgent or Emergent Research Results to Participants: The Project Baseline Health Study Experience.Neha Pagidipati, Brooke Heidenfelder, Lydia Coulter Kwee, Fatima Rodriguez, Ranee Chatterjee
American Journal of Medicine Open. 2025-06-01 - Designing the next generation of clinical trials in intermediate AMD-a consensus driven, pragmatic, proof of concept early intervention study.Robyn H Guymer, Philip J Rosenfeld, Justis P Ehlers, Mayssa Attar, Hao Chen
Experimental Eye Research. 2025-03-14 - Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity" [Am J Ophthalmol 2020;2...Jacque L Duncan, Wendi Liang, Maureen G Maguire, Isabelle Audo, Allison R Ayala
American Journal of Ophthalmology. 2025-03-07
Journal Articles
- Development, Validation, and Innovation in Ophthalmic Laser-Based ImagingFrank Brodie, Natalie Afshari, Jennifer E Thorne, Albert Vitale, David Myung, Mark S Blumenkranz, Elmer Tu, David Sarraf, Glenn J Jaffe, Malvina Eydelman, JAMA Ophthalmology
- Development, Validation, and Innovation in Ophthalmic Laser-Based ImagingFrank Brodie, Natalie Afshari, Jennifer E Thorne, Albert Vitale, David Myung, Mark S Blumenkranz, Elmer Tu, David Sarraf, Glenn J Jaffe, Malvina Eydelman, JAMA Ophthalmology
- Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical TrialGlenn Jaffe, MD, JAMA Ophthalmology
- Join now to see all
Press Mentions
ARVO Foundation Announces Recipient of 2025 Oberdorfer Award in Low Vision ResearchMarch 10th, 2025- LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve VisionNovember 4th, 2024
- Researchers Discover Therapeutic Target to Aid in Glaucoma TreatmentMarch 16th, 2023
- Join now to see all
Grant Support
- NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial with retinitis pigmentosa: OCT Reading CenterDUKE UNIVERSITY2022–2027
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
